Related Experiment Video
Updated: Mar 27, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
L1 cell adhesion molecule as a therapeutic target in cancer
Xinzhe Yu1, Feng Yang1, De-Liang Fu1
1a Department of Pancreatic Surgery, Huashan Hospital , Fudan University , Shanghai , China.
Abstract:
L1 cell adhesion molecule (L1CAM) is the prototype member of the L1-family of closely related neural adhesion molecules. L1CAM is differentially expressed in the normal nervous system as well as pathological tissues and displays a wide range of biological activities. In human malignancies, L1CAM plays a vital role in tumor growth, invasion and metastasis. Recently, increasing evidence has suggested that L1CAM exerts a variety of functions at different steps of tumor progression through a series of signaling pathways. In addition, L1CAM has been identified as a promising target for cancer therapy by using synthetic and natural inhibitors. In this review, we provide an up-to-date overview of the role of L1CAM involved in cancers and the rationale for L1CAM as a novel molecular target for cancer therapy.
Related Concept Videos
Selectins
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...
Cell Adhesion Molecules - Types and Functions
Targeted Cancer Therapies
There are several types of targeted therapies against...
Intracellular Signaling Affects Focal Adhesions
Some...

